Addus HomeCare Corporation (ADUS) Price Target Analysis
Updated Jun 18, 2026
Analyst Rating: Buy
Based on 16 analysts29.5% Below Target
ADUS trades 29.5% below Wall Street's consensus target of $122.00.
Current Price$94.23
Average Target$122.00
Target
Current
Low$92.00
Median$135.00
High$139.00
Analyst Target Range
Forward P/E13.5x
(Value)
PEG Ratio0.67
(Undervalued)
Implied Growth+29.5%
(High Growth)
Analyst Spread38.5%
(Moderate)
Price Forecast (1 Year)
Last 12 months price action with 12-month analyst target path
Consensus Scenario Assumptions
The base valuation assumes ADUS achieves its forward estimates and maintains a stable P/E multiple of 13.5x. This scenario reflects the blended consensus of 16 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
ADUS Price Target Analysis
Updated June 21, 2026As of June 21, 2026, Addus HomeCare Corporation (ADUS) has a Wall Street consensus price target of $122.00, based on estimates from 16 covering analysts. With the stock currently trading at $94.23, this represents a potential upside of +29.5%. The company has a market capitalization of $1.76B.
Analyst price targets range from a low of $92.00 to a high of $139.00, representing a 39% spread in expectations. The median target of $135.00 differs from the mean, suggesting potential outlier estimates.
The current analyst consensus rating is Buy, with 14 analysts rating the stock as a Buy or Strong Buy,1 rating it Hold, and 1 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, ADUS trades at a trailing P/E of 18.1x and forward P/E of 13.5x. The forward PEG ratio of 0.67 suggests the stock may be undervalued relative to its growth. Analysts expect EPS to grow +29.5% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $99.00, with bear and bull scenarios of $62.37 and $130.44 respectively. Model confidence stands at 57/100, reflecting moderate uncertainty in projections.
Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Healthcare stocks.
Analyst Sentiment Comparison
Industry Peer AnalysisAvg Peer Upside
+9.8%
Industry Consensus
Avg Forward P/E
45.5x
(Growth Premium)
Peers with Coverage
10 / 10
Active Analyst Tracking
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 HCSGHealthcare Services Group, Inc. | $1.6B | $22.94 | $24.50 | +6.8% | Hold | 21.2x | 15 |
 ENSGThe Ensign Group, Inc. | $9.0B | $153.65 | $222.33 | +44.7% | Buy | 20.3x | 13 |
 SGRYSurgery Partners, Inc. | $1.9B | $14.55 | $19.33 | +32.9% | Buy | 33.9x | 22 |
 ALHCAlignment Healthcare, Inc. | $4.5B | $21.86 | $24.33 | +11.3% | Buy | 118.7x | 16 |
 PNTGThe Pennant Group, Inc. | $1.2B | $33.44 | $39.00 | +16.6% | Buy | 24.7x | 7 |
 CCRNCross Country Healthcare, Inc. | $426M | $13.17 | $12.50 | -5.1% | Hold | 142.4x | 14 |
 UNHUnitedHealth Group Incorporated | $363.9B | $400.96 | $425.81 | +6.2% | Buy | 21.8x | 52 |
 CVSCVS Health Corporation | $125.4B | $98.32 | $103.64 | +5.4% | Buy | 13.3x | 41 |
 HUMHumana Inc. | $43.3B | $360.65 | $298.50 | -17.2% | Hold | 40.8x | 44 |
 CNCCentene Corporation | $30.1B | $61.02 | $59.00 | -3.3% | Buy | 17.5x | 43 |
ADUS — Frequently Asked Questions
Quick answers to the most common questions about buying ADUS stock.
What is the ADUS stock price target for 2026?
The consensus Wall Street price target for ADUS is $122, representing 29.5% upside from the current price of $94.23. With 16 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
Is ADUS a buy, sell, or hold?
ADUS has a consensus rating of "Buy" based on 16 Wall Street analysts. The rating breakdown is predominantly bullish, with 14 Buy/Strong Buy ratings. The consensus 12-month price target of $122 implies 29.5% upside from current levels.
Is ADUS stock overvalued or undervalued?
With a forward P/E of 13.4849x, ADUS trades at a relatively low valuation. The consensus target of $122 implies 29.5% appreciation, suggesting meaningful undervaluation.
How high can ADUS stock go?
The most bullish Wall Street analyst has a price target of $139 for ADUS, while the most conservative target is $92. The consensus of $122 represents the median expectation. Our quantitative valuation model projects a bull case target of $130 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
How many analysts cover ADUS stock?
ADUS is well covered by analysts, with 16 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 14 have Buy ratings, 1 recommend Hold, and 1 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
What is the ADUS stock forecast?
The 12-month ADUS stock forecast based on 16 Wall Street analysts shows a consensus price target of $122, with estimates ranging from $92 (bear case) to $139 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $99, with bear/bull scenarios of $62/$130.
What is ADUS's fair value based on fundamentals?
Our quantitative valuation model calculates ADUS's fair value at $99 (base case), with a bear case of $62 and bull case of $130. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 57/100.
What is ADUS's forward P/E ratio?
ADUS trades at a forward P/E ratio of 13.5x based on next-twelve-months earnings estimates compared to a trailing P/E of 18.1x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Should I buy ADUS stock?
Wall Street analysts are very optimistic on ADUS, with a "Buy" consensus rating and $122 price target (29.5% upside). 14 of 16 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
Why do ADUS price targets vary so much?
ADUS analyst price targets range from $92 to $139, a 39% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $122 consensus represents the middle ground. Our model's $62-$130 range provides an independent fundamental perspective.
Consensus-Based Analysis Tools
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Check Valuation
Historical Returns
10-year return with dividends reinvested.
Calculate
DCA Calculator
See how regular investing compounds over time.
Run Numbers
Peer Comparison
Compare growth, multiples, and margins vs sector.
Compare